Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
<h4>Unlabelled</h4>Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early du...
Saved in:
Main Authors: | Thomas Viel, Sonja Schelhaas, Stefan Wagner, Lydia Wachsmuth, Katrin Schwegmann, Michael Kuhlmann, Cornelius Faber, Klaus Kopka, Michael Schäfers, Andreas H Jacobs |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/5b83a89cb35d464b98a1abc32bdbe18f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
by: Bin Huang, et al.
Published: (2021) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas RP, et al.
Published: (2012) -
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
by: Nadja I. Lorenz, et al.
Published: (2021) -
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
by: Tae Hoon Roh, et al.
Published: (2020) -
Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells
by: Selva Rupa Christinal Immanuel, et al.
Published: (2021)